2022/07/06 News Release UBE Corporation to Begin Basic Design for DMC and EMC Plant Construction in the U.S.
2022/06/10 News Release Santen and UBE announces U.S. Food and Drug Administration accepts resubmission of NDA for STN1011700 / DE-117 (omidenepag isopropyl) for treating glaucoma and ocular hypertension
2022/05/28 IR News (Presentation and Q&A Transcript) Telephone Conference for the FY2021 Consolidated Results / FY2022 Consolidated Forecasts
2022/05/19 IR News "UBE Vision 2030 Transformation~1st Stage~" Management Overview Briefing (May 2022)
2022/05/19 IR News UBE Group Unveils New Medium-Term Management Plan "UBE Vision 2030 Transformation--1st Stage"
2022/05/12 IR News Telephone Conference for the FY2021 Consolidated Results / FY2022 Consolidated Forecasts
2022/04/28 News Release UBE Corporation Announces Change of Representative Director and Personnel Change
2022/04/12 News Release UBE Group Announces New Medium-Term Targets by 2030 for Achieving Carbon Neutrality by 2050
2022/04/07 News Release UBE Corporation Selected as a Constituent of FTSE Blossom Japan Sector Relative Index